Presentations to Detail Latest Cardiac Surgery Technology to be Held
January 26th at 6:30 p.m. Eastern Time
FORT LAUDERDALE, Fla., Jan. 15 /PRNewswire-FirstCall/ -- Five leading medical technology companies will host the first annual After Hours Event on January 26, 2008 at 6:30 p.m. in Fort Lauderdale, aboard the yacht "Princess Lady." The invitation-only event, immediately preceding the largest meeting of cardiothoracic surgeons in North America, will feature comprehensive presentations and open discussions by renowned cardiac and thoracic surgeons highlighting the latest medical therapies and technologies.
Presentations scheduled for the event include:
Autofluorescence Brochoscopy and Photodynamic Therapy: A Thoracic Surgeon's Perspective by Patrick Ross Jr., M.D., Ph.D., associate professor and director of general surgery at the Arthur G. James Cancer Hospital and Solove Research Institute in Columbus, Ohio;
Why Go On Pump?: A Clinical and Economic Perspective of Why Our Practice Converted to OPCAB with the C-Port xA(R) Distal Anastomosis System by Nicholas V. Augelli, M.D., cardiothoracic surgeon for the Genesis Heart Institute in Davenport, Iowa;
Closed-Chest, Beating Heart Cardiac Ablation with the SOLAR(TM) System by Husam Balkhy, M.D., chairman of the department of cardiothoracic surgery for The Wisconsin Heart Hospital in Wauwatosa, Wis.;
SPY Intra-Operative Imaging in Graft Assessment by David Paul Taggart, M.D., Ph.D., FRCS, professor of cardiovascular surgery for the John Radcliffe Hospital in Oxford, UK; and
Intra-Operative Assessment of Flow Measurement through a Limited Thoracotomy in Robotic Surgery by Francis Sutter, D.O., FACS, clinical professor of surgery for Jefferson Medical College and cardiothoracic surgeon for Lankenau Hospital in Philadelphia, Pa.
The event is sponsored by Axcan Pharma (Nasdaq: AXCA; TSX: AXP), Cardica, Inc. (Nasdaq: CRDC), MedicalCV, Inc. (OTC Bulletin Board: MCVI), Novadaq Technologies (TSX: NDQ) and Transonic Systems Inc. This activity is not considered part of the official scientific sessions for STS. For more information on the After Hours Event, please log on to http://www.ctsurgeon-event.com.
About Axcan Pharma
Axcan Pharma is a leading multinational specialty pharmaceutical company focused on gastroenterology. Axcan markets Photofrin(R), a photosensitizing agent used in the photodynamic therapy of tumors and of high grade dysplasia in Barrett's esophagus.
Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is developing additional devices with Cook Incorporated to facilitate vascular closure and other surgical procedures.
MedicalCV, Inc. is a medical device company that develops, manufactures and sells innovative, laser-based surgical ablation systems to create precise, clinically relevant lesions, or scars, in both soft and cardiac tissue. The Company's core products are the SOLAR(TM) and ATRILAZE(TM) Surgical Ablation Systems for use in soft and cardiac tissue ablation procedures, respectively. Both the SOLAR(TM) and ATRILAZE(TM) Systems have been utilized in concomitant open-heart and, by some cardiothoracic surgeons, in minimally invasive cardiac surgery procedures. The Company's common stock is traded on the OTC Bulletin Board under the symbol "MCVI."
About Novadaq Technologies
Novadaq Technologies Inc. (TSX: NDQ) develops and commercializes medical imaging systems and real-time image guided therapies for use in the operating room. Novadaq's proprietary ICG imaging systems can be used to visualize blood vessels, nerves and the lymphatic system during a variety of surgical procedures. Novadaq's SPY(R) Imaging System, commercially available worldwide, enables cardiac surgeons to visually assess coronary vasculature and bypass graft functionality during the course of heart bypass surgery. The SPY System is expandable to include upgrade kits for use during other surgeries such as plastic, reconstructive and organ transplant surgery allowing surgeons to evaluate blood flow and tissue and organ perfusion. In addition, SPY is ideal for use during urological procedures enabling surgeons to visualize vessels, tumors, the lymphatic system and potentially nerve bundles. Novadaq's OPTTX(R) System is aimed at the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD) by using the same core imaging technology that is used in the SPY Imaging System. Novadaq also offers the FDA approved PINPOINT(TM) endoscopic system for visualizing native tissue fluorescence which allows surgeons to differentiate between healthy and cancerous tissue in the lung during thoracic surgery. Novadaq is also the exclusive United States distributor of PLC Medical's CO2 HEART LASER(TM) System for TMR (Trans- Myocardial Revascularization). For more information, please visit the company's website at http://www.novadaq.com.
About Transonic Systems
Transonic Systems Inc. (http://www.transonic.com) designs, manufactures and markets biomedical flow measurement devices. From the laboratory to the operating room, our precision devices deliver quantitative and reliable flow data to surgeons, nephrologists, interventional radiologists and research scientists earning the company its reputation as the industry leader in biomedical flow measurement. Headquartered in Ithaca, New York, with subsidiaries in the Netherlands and Taiwan, the company sells it transit-time ultrasound flowmeters, hemodialysis, laser Doppler perfusion and angioplasty monitors throughout the world. Transonic flow sensors are used in heart bypass machines and intraoperatively during coronary artery bypass grafting and other surgeries to confirm adequate flows.
|SOURCE Axcan Pharma; Cardica, Inc.; MedicalCV, Inc.; NovadaqTechnologies;|
Copyright©2008 PR Newswire.
All rights reserved